Winnipeg Free Press - PRINT EDITION
Posted: 04/20/2013 1:00 AM | Comments: 0
TORONTO -- Health Canada says companies involved in the compounding and admixing of medications can continue to do so, but under new oversight conditions.
The conditions are a temporary fix to a jurisdictional grey area believed to have contributed to more than 1,200 patients receiving diluted chemotherapy drugs.
Dr. Supriya Sharma, senior medical adviser with Health Canada, says the conditions will allow companies to continue providing services while Ottawa and the provinces and territories work out a long-term oversight plan.
Compounding and admixing can continue if it is done within a hospital meeting provincial requirements, outside a hospital under the supervision of a provincially licensed pharmacist, or in a manner that meets the licensing and manufacturing requirements of the Food and Drugs Act.
Marchese Hospital Solutions provided the watered-down drugs to five hospitals in Ontario and New Brunswick, but has said the problem was with how the drugs were administered at hospitals.
However, the new conditions might not have prevented the incident, as Sharma says Marchese is believed to have been working under appropriate oversight.
"From the information that we have obtained from Marchese Hospital Solutions, we do believe that they had appropriate oversight in place," Sharma said Friday.
Marchese Hospital Solutions, which had a pharmacist on staff, fell into a jurisdictional grey area, with Health Canada and the Ontario College of Pharmacists unable to agree on who was responsible for the facility.
Health Canada regulates and inspects drug manufacturers, while the college is responsible for pharmacists in Ontario, including those who may have been working independently for the company. Hospitals are responsible for the purchase and security of their drugs.
Too much saline was added to the bags containing cyclophosphamide and gemcitabine, in effect watering down the prescribed drug concentrations by up to 20 per cent. Some patients were taking the drugs for as long as a year.
Sharma said Canadians can be reassured that organizations following the new guidelines "will have the active oversight in place to help ensure the safety and effectiveness of health products prepared in this way."
The Ontario government said Friday it is posting a new regulation under the Public Hospitals Act to ensure hospitals purchase drugs only from accredited, licensed or otherwise approved suppliers.
The province is also working with the Ontario College of Pharmacists on a regulation to give the college the power to inspect premises where pharmacists and pharmacy technicians practise, including where drugs are prepared.
The government is also contacting businesses in Ontario that may be selling compounded drugs to obtain more information about their activities.
All Ontario hospitals have been asked to confirm that quality-assurance processes are in place for all drugs purchased externally or prepared in the hospital.
"Ontario's actions, combined with Health Canada's commitment, will ensure that patients in Ontario hospitals can have full confidence in the safety of their drug treatments," Deb Matthews, Minister of Health and Long-Term Care, said in a statement.
"However, this is national problem, and the federal government has an important responsibility in providing a long-term solution," Matthews noted.
Ontario NDP health critic France Gelinas said the federal government has now made it clear who is responsible for drug compounding and admixing companies.
"The federal government made it really clear their oversight is going to stop at manufacturing -- everything else is the responsibility of the province," Gelinas said.
-- The Canadian Press
Republished from the Winnipeg Free Press print edition April 20, 2013 A18
Have you found an error, or know of something we’ve missed in one of our stories? Please use the form below and let us know.
Having problems with the form?Contact Us Directly
Illnesses prompt Toronto meat recall
Searching for a theory on survival
Training Basket: Leila Mostaço-Guidolin
Sun's damage continues after exposure
Bus beheader could be moved to group home
A list of decisions in the case of Vince Li
Health Canada warns about bedbug poison after deaths
Added salt and sugar in kids' foods dangerous
Another child dies after exposure to insecticide
Tories on hot seat over dying Alberta man
Aboriginal girl's parents explain daughter's death
WHO warns of global flu pattern volatility
Panel: Use new meningitis vaccines only for outbreaks
Labour bill for merger not under deadline
Panel: Base quarantines, other outbreak decisions on science
Nova Scotia moves ahead with health authority
Ebola doctor: Media, politicians fueled the public's fear
Cereal recalled due to pieces of plastic
Harper urges parents to vaccinate kids
Dying man fights for disability benefits
Abortion issue still flares in New Brunswick
Ontario to fund costly drug on interim basis
P.E.I. carbon monoxide death prompts warning
Spa official ordered to stop practising medicine
Shortage of midwives means no home births in Regina
3 Austrians get bionic hands after amputation
Mentally ill soldier more likely to be let go
Pills before and after sex can help prevent HIV, study finds
Abortion access questioned in New Brunswick
Nurses to seek charges against violent patients
Farm insecticide in Alberta apartment killed baby
Feds send mixed signals on assisted death law
Head doctor, heart doctor
Merck grants free license for pediatric HIV drug
NY attorney general expands herbal supplements investigation
Lawmaker asks if swallowed camera be used for female exam
Ebola drug shows some promise in first tests in West Africa
Sex ed necessary in digital age, experts say
Baby's death linked to insecticide: fire official
Early exposure to peanuts helps prevent allergies in kids